Median age (y) | 66 | 68 |
Sex (male:female) | 25:16 | 25:16 |
Primary tumor etiology | | |
Hepatocellular carcinoma | 19 | 19 |
Intrahepatic cholangiocarcinoma | 5 | 5 |
Colorectal cancer | 6 | 6 |
Neuroendocrine tumor | 6 | 6 |
Gastrointestinal stromal tumor | 1 | 1 |
Breast cancer | 1 | 1 |
Ocular melanoma | 1 | 1 |
Ovarian cancer | 1 | 1 |
Adenocarcinoma (of undefined origin) | 1 | 1 |
Mean lung shunt fraction ± SD (%) | 5.9 ± 2.7 | 5.2 ± 2.3 |
No. of prior antiangiogenic therapies | 4 | 4 |
Tumor involvement (%) | | |
Mean ± SD | 33.5 ± 22.5 | 29.2 ± 20.4 |
Median | 30 | 28 |
90Y activity (MBq) | | |
Mean | Calculated, 1,620/applied, 1,593 | Calculated, 1,558/applied, 1,455 |
Median | Calculated, 1,633/applied, 1,537 | Calculated, 1,600/applied, 1,502 |
SD | Calculated, 390/applied, 406 | Calculated, 369/applied, 380 |